Accessibility: Skip TopNav
Nebokitug Treatment for 48 Weeks Stabilizes Risk of Disease Progression as Determined by ELF Score
Nebokitug Treatment for 48 Weeks Stabilizes Risk of Disease Progression as Determined by ELF Score
Format
PNG
Source
Chemomab Therapeutics
Downloads
Original
Large
Medium
Small